ArticleMaterials (Basel, Switzerland)2026
Porous Curdlan-Whey Protein Isolate Scaffolds Obtained by Combined Method for Cartilage Tissue Engineering Application.
Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The aim of this study was to develop porous curdlan (Cur)-whey protein isolate (WPI) biomaterials and evaluate their properties as potential cartilage scaffolds. A novel combined fabrication method involving ion-exchange dialysis, porogen leaching, freezing, and freeze-drying was employed to obtain a porous structure. Two types of scaffolds differing in protein content (5 wt.% and 7.5 wt.%) were fabricated and designated as Cur_WPI_5% and Cur_WPI_7.5%, respectively. The microstructure of the biomaterials was analyzed using stereomicroscopy and scanning electron microscopy coupled with energy-dispersive X-ray spectroscopy (SEM-EDS). Physicochemical properties, including wettability and absorption capacity, were also evaluated. In addition, the viability and proliferation of osteoblasts (hFOB 1.19 cell line) in direct contact with scaffolds were assessed. The results demonstrated that both biomaterials exhibited a porous, rough, and hydrophilic structure, as well as a high liquid absorption capacity. Cell culture studies revealed that the Cur_WPI_7.5% scaffold showed greater cytocompatibility, promoting not only osteoblast viability and but also proliferation in vitro. Overall, these findings demonstrate that the developed curdlan/WPI scaffolds, particularly Cur_WPI_7.5%, possess structural and physicochemical properties favorable for cartilage tissue regeneration, highlighting their potential as promising scaffold for future applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.